Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02467738 · ClinicalTrials.gov registry record · Early Phase 1
Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
A Early Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT02467738 is a Early Phase 1 study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 30 participants.
The verdict
NCT02467738, a Early Phase 1 study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This pilot clinical trial studies cesium Cs 131 brachytherapy in treating patients with head and neck cancer that has come back (recurrent) and can be removed by surgery. Brachytherapy, also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Radioactive drugs, such as cesium Cs 131, may carry radiation directly to tumor cells and not harm normal cells. Permanently implanting cesium Cs 131 into the wound bed after surgery may help treat microscopic cancer cells that may be in the tissue after surgical removal of the tumor.
Interventions
- RADIATION Brachytherapy
- PROCEDURE Conventional surgery
- DRUG Cesium-131
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-03-17 |
| Est. Completion | 2020-05-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02467738
The ClinicalTrials.gov registry entry for NCT02467738 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Brachytherapy is the first listed.
NCT02467738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02467738 about?
NCT02467738 is a clinical study titled "Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer". This pilot clinical trial studies cesium Cs 131 brachytherapy in treating patients with head and neck cancer that has come back (recurrent) and can be removed by surgery. Brachytherapy, also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill t...
What is the current status of trial NCT02467738?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2015-03-17. Estimated completion is 2020-05-28.
What interventions are being tested in trial NCT02467738?
The interventions under investigation include: Brachytherapy (RADIATION), Conventional surgery (PROCEDURE), Cesium-131 (DRUG).
Who is sponsoring clinical trial NCT02467738?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.